Xylem
- Home ›
- US ›
- Capital Goods
Xylem Inc. engages in the design, manufacture, and servicing of engineered products and solutions for the water and wastewater applications. The last earnings update was 60 days ago. More info.
Add to Portfolio Compare Print
XYL Share Price and Events
7 Day Returns
1 Year Returns
XYL Shareholder Return
| 7 Day | 30 Day | 90 Day | 1 Year | 3 Year | 5 Year | |
|---|---|---|---|---|---|---|
| Xylem (XYL) | 1.3% | 8.3% | 22.1% | 10.6% | 94.8% | 129.1% |
| US Machinery | 1.4% | 9.3% | 11.6% | 1.8% | 51.4% | 34% |
| US Market | -0.8% | 2.7% | 7.5% | 7% | 37.9% | 47% |
1 Year Return vs Industry and Market
- XYL outperformed the Machinery industry which returned 1.8% over the past year.
- XYL outperformed the Market in United States of America which returned 7% over the past year.
Value
Is Xylem undervalued based on future cash flows and its price relative to the stock market?
Value is all about what a company is worth versus what price it is
available for. If you went into a grocery store and all the bananas were on sale
at half price, they could be considered
undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current
share
price of
Xylem
to its discounted cash flow analysis.value.The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Below are the data sources, inputs and calculation used to determine the intrinsic value for Xylem.
| Data Point | Source | Value |
|---|---|---|
| Valuation Model | 2 Stage Free Cash Flow to Equity | |
| Levered Free Cash Flow | Average of 17 Analyst Estimates (S&P Global) | See below |
| Discount Rate (Cost of Equity) | See below | 9.5% |
| Perpetual Growth Rate | 10-Year US Government Bond Rate | 2.7% |
An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.
| Data Point | Calculation/ Source | Result |
|---|---|---|
| Risk-Free Rate | 10-Year US Govt Bond Rate | 2.7% |
| Equity Risk Premium | S&P Global | 6% |
| Machinery Unlevered Beta | Simply Wall St/ S&P Global | 1.07 |
| Re-levered Beta | = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 1.068 (1 + (1- 21%) (15.37%)) |
1.132 |
| Levered Beta | Levered Beta limited to 0.8 to 2.0 (practical range for a stable firm) |
1.13 |
| Discount Rate/ Cost of Equity |
= Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 2.73% + (1.132 * 5.96%) |
9.48% |
Discounted Cash Flow Calculation for NYSE:XYL using 2 Stage Free Cash Flow to Equity Model
The calculations below outline how an intrinsic value for Xylem is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.
| Levered FCF (USD, Millions) | Source |
Present Value Discounted (@ 9.48%) |
|
|---|---|---|---|
| 2019 | 642.01 | Analyst x8 | 586.42 |
| 2020 | 736.94 | Analyst x8 | 614.84 |
| 2021 | 810.40 | Analyst x4 | 617.59 |
| 2022 | 918.95 | Analyst x2 | 639.67 |
| 2023 | 906.00 | Analyst x1 | 576.05 |
| 2024 | 904.41 | Est @ -0.18% | 525.25 |
| 2025 | 910.71 | Est @ 0.7% | 483.11 |
| 2026 | 922.61 | Est @ 1.31% | 447.05 |
| 2027 | 938.60 | Est @ 1.73% | 415.42 |
| 2028 | 957.68 | Est @ 2.03% | 387.16 |
| Present value of next 10 years cash flows | $5,292.57 | ||
| Calculation | Result | |
|---|---|---|
| Terminal Value |
= FCF2028
× (1 + g) ÷ (Discount Rate – g)
= $957.68 × (1 + 2.73%) ÷ (9.48% – 2.73%) |
$14,576.08 |
| Present Value of Terminal Value |
= Terminal Value ÷ (1 + r)10
= $14,576.08 ÷ (1 + 9.48%)10 |
$5,892.63 |
| Calculation | Result | |
|---|---|---|
| Total Equity Value |
= Present value of next 10 years cash flows +
Terminal Value
= $5,292.57 + $5,892.63 |
$11,185.20 |
| Equity Value per Share (USD) |
= Total value / Shares Outstanding
= $11,185.20 / 179.85 |
$62.19 |
| Calculation | Result | |
|---|---|---|
| Value per share (USD) | From above. | $62.19 |
| Current discount | Discount to share price of
$83.49
= -1 x ($83.49 - $62.19) / $62.19 |
-34.2% |
Learn more about our DCF calculations in Simply Wall St’s analysis model .
- The current share price of Xylem is above its future cash flow value.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for
it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing
when they are out of season, or how much your home is worth.The amount the stock market is willing to pay for Xylem's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are
Xylem's earnings available for a low price, and how does
this compare to other companies in the same industry?
| Data Point | Source | Value |
|---|---|---|
| Earnings Per Share * | Company Filings (2018-12-31) in USD | $3.05 |
| NYSE:XYL Share Price ** | NYSE (2019-04-22) in USD | $83.49 |
| United States of America Machinery Industry PE Ratio | Median Figure of 103 Publicly-Listed Machinery Companies | 21.67x |
| United States of America Market PE Ratio | Median Figure of 3,080 Publicly-Listed Companies | 18.21x |
* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.
** Primary Listing of Xylem.
| Calculation | Outcome | |
|---|---|---|
| PE Ratio | = NYSE:XYL Share Price ÷ EPS (both in USD) = 83.49 ÷ 3.05 |
27.34x |
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Xylem is overvalued based on earnings compared to the US Machinery industry average.
- Xylem is overvalued based on earnings compared to the United States of America market.
Price based on expected Growth
Does
Xylem's expected growth come at a high price?
| Data Point | Source | Value |
|---|---|---|
| PE Ratio | See PE Ratio Section | 27.34x |
| Net Income Annual Growth Rate | See Future Growth Section. Line of Best Fit* through Consensus Estimate Earnings of 17 Analysts |
9.5%per year |
| United States of America Machinery Industry PEG Ratio | Median Figure of 83 Publicly-Listed Machinery Companies | 1.61x |
| United States of America Market PEG Ratio | Median Figure of 2,109 Publicly-Listed Companies | 1.56x |
*Line of best fit is calculated by linear regression .
| Calculation | Outcome | |
|---|---|---|
| PEG Ratio | = PE Ratio ÷ Net Income Annual Growth Rate = 27.34x ÷ 9.5% |
2.88x |
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Xylem is poor value based on expected growth next year.
Price based on value of assets
What value do investors place on
Xylem's
assets?
| Data Point | Source | Value |
|---|---|---|
| Book Value per Share | Company Filings (2018-12-31) in USD | $15.40 |
| NYSE:XYL Share Price * | NYSE (2019-04-22) in USD | $83.49 |
| United States of America Machinery Industry PB Ratio | Median Figure of 129 Publicly-Listed Machinery Companies | 2.45x |
| United States of America Market PB Ratio | Median Figure of 5,186 Publicly-Listed Companies | 1.91x |
| Calculation | Outcome | |
|---|---|---|
| PB Ratio | = NYSE:XYL Share Price ÷ Book Value per Share (both in USD) = 83.49 ÷ 15.40 |
5.42x |
* Primary Listing of Xylem.
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Xylem is overvalued based on assets compared to the US Machinery industry average.
Value checks
We assess Xylem's value by looking at:- Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
- Is the PE ratio less than the market average, and/ or less than the Machinery industry average (and greater than 0)? (2 checks)
- Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
- Is the PB ratio less than the Machinery industry average (and greater than 0)? (1 check) Xylem has a total score of 0/6, see the detailed checks below.
Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.
Full details on the Value part of the Simply Wall St company analysis model.
Future Performance
How is Xylem expected to perform in the next 1 to 3 years based on estimates from 17 analysts?
The future performance of a company is measured in the same way as past
performance, by looking at estimated
growth
and how much profit it is expected to make.Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Earnings growth vs Low Risk Savings
- Xylem's earnings growth is expected to exceed the low risk savings rate of 2.7%.
Growth vs Market Checks
- Xylem's earnings growth is positive but not above the United States of America market average.
- Xylem's revenue growth is positive but not above the United States of America market average.
Annual Growth Rates Comparison
| Data Point | Source | Value (per year) |
|---|---|---|
| NYSE:XYL Future Earnings Growth Rate | Line of Best Fit* through Consensus Estimate Earnings of 17 Analysts | 9.5% |
| NYSE:XYL Future Revenue Growth Rate | Line of Best Fit* through Consensus Estimate Revenue of 17 Analysts | 4.4% |
| United States of America Machinery Industry Earnings Growth Rate | Market Cap Weighted Average | 11% |
| United States of America Machinery Industry Revenue Growth Rate | Market Cap Weighted Average | 3.7% |
| United States of America Market Earnings Growth Rate | Market Cap Weighted Average | 13.5% |
| United States of America Market Revenue Growth Rate | Market Cap Weighted Average | 7% |
*Line of best fit is calculated by linear regression .
Industry and Market average data is calculated daily.
Learn more about our growth rate calculations in Simply Wall St’s analysis model.
Analysts growth expectations
| Data Point | Source | Value |
|---|---|---|
| Past Financials | Company Filings (3 months ago) | See Below |
| Future Estimates | Average of up to 17 Analyst Estimates (S&P Global) | See Below |
| Date (Data in USD Millions) | Revenue | Cash Flow | Net Income * | Avg. No. Analysts |
|---|---|---|---|---|
| 2023-12-31 | 6,529 | 1,135 | 860 | 1 |
| 2022-12-31 | 6,258 | 1,138 | 805 | 1 |
| 2021-12-31 | 5,956 | 1,067 | 747 | 4 |
| 2020-12-31 | 5,702 | 956 | 680 | 17 |
| 2019-12-31 | 5,420 | 867 | 581 | 16 |
| Date (Data in USD Millions) | Revenue | Cash Flow | Net Income * |
|---|---|---|---|
| 2018-12-31 | 5,207 | 586 | 549 |
| 2018-09-30 | 5,098 | 695 | 395 |
| 2018-06-30 | 5,006 | 736 | 370 |
| 2018-03-31 | 4,853 | 697 | 354 |
| 2017-12-31 | 4,707 | 686 | 331 |
| 2017-09-30 | 4,525 | 602 | 310 |
| 2017-06-30 | 4,227 | 523 | 278 |
| 2017-03-31 | 3,995 | 508 | 250 |
| 2016-12-31 | 3,771 | 497 | 260 |
| 2016-09-30 | 3,670 | 478 | 324 |
| 2016-06-30 | 3,675 | 466 | 339 |
| 2016-03-31 | 3,663 | 466 | 342 |
*GAAP earnings excluding extraordinary items.
Past and Future Earnings per Share
| Data Point | Source | Value |
|---|---|---|
| Past Financials | Company Filings (3 months ago) | See Below |
| Future Estimates | Average of up to 17 Analyst Estimates (S&P Global) | See Below |
All data from Xylem Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.
| Date (Data in USD Millions) | EPS * | EPS High Estimate | EPS Low Estimate | Avg. No. Analysts |
|---|---|---|---|---|
| 2023-12-31 | 5.70 | 5.70 | 5.70 | 1.00 |
| 2022-12-31 | 5.10 | 5.10 | 5.10 | 1.00 |
| 2021-12-31 | 4.33 | 4.55 | 4.10 | 3.00 |
| 2020-12-31 | 3.76 | 3.99 | 3.31 | 13.00 |
| 2019-12-31 | 3.18 | 3.37 | 2.86 | 12.00 |
| Date (Data in USD Millions) | EPS * |
|---|---|
| 2018-12-31 | 3.05 |
| 2018-09-30 | 2.20 |
| 2018-06-30 | 2.06 |
| 2018-03-31 | 1.97 |
| 2017-12-31 | 1.84 |
| 2017-09-30 | 1.73 |
| 2017-06-30 | 1.55 |
| 2017-03-31 | 1.39 |
| 2016-12-31 | 1.45 |
| 2016-09-30 | 1.81 |
| 2016-06-30 | 1.89 |
| 2016-03-31 | 1.90 |
*GAAP earnings excluding extraordinary items.
Future performance checks
We assess Xylem's future performance by looking at:- Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
- Is the annual earnings growth rate expected to beat the average growth rate in earnings of the United States of America market? (1 check)
- Is the annual revenue growth rate expected to beat the average growth rate in revenue of the United States of America market? (1 check)
- Is the annual earnings growth rate expected to be above 20%? (1 check)
- Is the annual revenue growth rate expected to be above 20%? (1 check)
- Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Xylem has a total score of 2/6, see the detailed checks below.
Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.
Full details on the Future part of the Simply Wall St company analysis model.
Past Performance
How has Xylem performed over the past 5 years?
The past performance of a company can be measured by how much
growth
it has experienced and how much profit it makes relative to the funds and assets
it has available.
Past earnings growth
Past Earnings growth analysis
- Xylem's year on year earnings growth rate has been positive over the past 5 years.
- Xylem's 1-year earnings growth exceeds its 5-year average (65.9% vs 7.7%)
- Xylem's earnings growth has exceeded the US Machinery industry average in the past year (65.9% vs 27.9%).
Earnings and Revenue History
All data from Xylem Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.
| Date (Data in USD Millions) | Revenue | Net Income * | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 2018-12-31 | 5,207.00 | 549.00 | 1,150.00 | 189.00 |
| 2018-09-30 | 5,098.00 | 395.00 | 1,158.00 | 186.00 |
| 2018-06-30 | 5,006.00 | 370.00 | 1,133.00 | 185.00 |
| 2018-03-31 | 4,853.00 | 354.00 | 1,110.00 | 179.00 |
| 2017-12-31 | 4,707.00 | 331.00 | 1,072.00 | 181.00 |
| 2017-09-30 | 4,525.00 | 310.00 | 1,023.00 | 166.00 |
| 2017-06-30 | 4,227.00 | 278.00 | 983.00 | 144.00 |
| 2017-03-31 | 3,995.00 | 250.00 | 940.00 | 127.00 |
| 2016-12-31 | 3,771.00 | 260.00 | 895.00 | 110.00 |
| 2016-09-30 | 3,670.00 | 324.00 | 878.00 | 99.00 |
| 2016-06-30 | 3,675.00 | 339.00 | 876.00 | 99.00 |
| 2016-03-31 | 3,663.00 | 342.00 | 867.00 | 97.00 |
| 2015-12-31 | 3,653.00 | 340.00 | 854.00 | 95.00 |
| 2015-09-30 | 3,701.00 | 322.00 | 846.00 | 97.00 |
| 2015-06-30 | 3,762.00 | 340.00 | 861.00 | 98.00 |
| 2015-03-31 | 3,847.00 | 352.00 | 885.00 | 100.00 |
| 2014-12-31 | 3,916.00 | 337.00 | 920.00 | 104.00 |
| 2014-09-30 | 3,907.00 | 309.00 | 901.00 | 104.00 |
| 2014-06-30 | 3,909.00 | 276.00 | 929.00 | 104.00 |
| 2014-03-31 | 3,864.00 | 236.00 | 925.00 | 105.00 |
| 2013-12-31 | 3,837.00 | 228.00 | 942.00 | 104.00 |
| 2013-09-30 | 3,773.00 | 233.00 | 951.00 | 104.00 |
| 2013-06-30 | 3,739.00 | 232.00 | 931.00 | 104.00 |
| 2013-03-31 | 3,745.00 | 275.00 | 913.00 | 104.00 |
| 2012-12-31 | 3,791.00 | 297.00 | 914.00 | 106.00 |
| 2012-09-30 | 3,825.00 | 276.00 | 912.00 | 107.00 |
| 2012-06-30 | 3,833.00 | 281.00 | 896.00 | 106.00 |
*GAAP earnings excluding extraordinary items.
Performance last year
We want to ensure a company is making the most of what it has available. This is
done by comparing the return (profit) to a company's available
funds,
assets
and
capital.
- Xylem has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
- Xylem used its assets more efficiently than the US Machinery industry average last year based on Return on Assets.
- Xylem's use of capital has not improved over the past 3 years (Return on Capital Employed).
Past performance checks
We assess Xylem's performance over the past 5 years by checking for:- Has earnings increased in past 5 years? (1 check)
- Has the earnings growth in the last year exceeded that of the Machinery industry? (1 check)
- Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
- Is the Return on Equity (ROE) higher than 20%? (1 check)
- Is the Return on Assets (ROA) above industry average? (1 check)
- Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
Xylem has a total score of 4/6, see the detailed checks below.
Note: We use GAAP Net Income excluding extraordinary items in all our calculations.
Full details on the Past part of the Simply Wall St company analysis model.
Health
How is Xylem's financial health and their level of debt?
A company's financial position is much like your own financial position,
it includes everything you own
(assets)
and owe
(liabilities).The boxes below represent the relative size of what makes up Xylem's finances.
The net worth of a company is the difference between its assets and liabilities.
- Xylem is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- Xylem's long term commitments exceed its cash and other short term assets.
Balance sheet
Assets
Liabilities and shares
- Low level of unsold assets.
- Debt is not covered by short term assets, assets are 0.9x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t
bad,
however if the debt is too high, or the company can’t afford to pay the interest
on its debts this may have impacts in the future.The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.
If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
All data from Xylem Company Filings, last reported 3 months ago.
| Date (Data in USD Millions) | Total Equity | Total Debt | Cash & Short Term Investments |
|---|---|---|---|
| 2018-12-31 | 2,782.00 | 2,308.00 | 296.00 |
| 2018-09-30 | 2,631.00 | 2,531.00 | 404.00 |
| 2018-06-30 | 2,529.00 | 2,540.00 | 321.00 |
| 2018-03-31 | 2,557.00 | 2,599.00 | 297.00 |
| 2017-12-31 | 2,519.00 | 2,200.00 | 414.00 |
| 2017-09-30 | 2,480.00 | 2,286.00 | 283.00 |
| 2017-06-30 | 2,382.00 | 2,411.00 | 288.00 |
| 2017-03-31 | 2,268.00 | 2,387.00 | 287.00 |
| 2016-12-31 | 2,207.00 | 2,368.00 | 308.00 |
| 2016-09-30 | 2,227.00 | 1,210.00 | 659.00 |
| 2016-06-30 | 2,174.00 | 1,234.00 | 586.00 |
| 2016-03-31 | 2,159.00 | 1,873.00 | 1,193.00 |
| 2015-12-31 | 2,084.00 | 1,274.00 | 680.00 |
| 2015-09-30 | 2,043.00 | 1,275.00 | 611.00 |
| 2015-06-30 | 2,080.00 | 1,277.00 | 600.00 |
| 2015-03-31 | 1,989.00 | 1,276.00 | 554.00 |
| 2014-12-31 | 2,127.00 | 1,284.00 | 663.00 |
| 2014-09-30 | 2,193.00 | 1,240.00 | 529.00 |
| 2014-06-30 | 2,245.00 | 1,242.00 | 450.00 |
| 2014-03-31 | 2,229.00 | 1,243.00 | 466.00 |
| 2013-12-31 | 2,241.00 | 1,241.00 | 533.00 |
| 2013-09-30 | 2,158.00 | 1,202.00 | 394.00 |
| 2013-06-30 | 2,052.00 | 1,204.00 | 360.00 |
| 2013-03-31 | 2,040.00 | 1,205.00 | 375.00 |
| 2012-12-31 | 2,074.00 | 1,205.00 | 504.00 |
| 2012-09-30 | 2,054.00 | 1,212.00 | 424.00 |
| 2012-06-30 | 1,948.00 | 1,206.00 | 358.00 |
- Xylem's level of debt (83%) compared to net worth is high (greater than 40%).
- The level of debt compared to net worth has increased over the past 5 years (55.4% vs 83% today).
- Debt is well covered by operating cash flow (25.4%, greater than 20% of total debt).
- Interest payments on debt are well covered by earnings (EBIT is 8.9x coverage).
Financial health checks
We assess Xylem's financial health by checking for:- Are short term assets greater than short term liabilities? (1 check)
- Are short term assets greater than long term liabilities? (1 check)
- Has the debt to equity ratio increased in the past 5 years? (1 check)
- Is the debt to equity ratio over 40%? (1 check)
- Is the debt covered by operating cash flow? (1 check)
- Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check) Xylem has a total score of 3/6, see the detailed checks below.
- Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
- Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
Full details on the Health part of the Simply Wall St company analysis model.
Dividends
What is Xylem's current dividend yield, its reliability and sustainability?
Dividends are regular cash payments to you from the company, similar to a
bank paying you interest on a savings account.
Annual Dividend Income
If you bought
$2,000 of
Xylem
shares you are expected to receive
$23
in your first year as a dividend.
Dividend Amount
- Xylem's pays a lower dividend yield than the bottom 25% of dividend payers in United States of America (1.39%).
- Xylem's dividend is below the markets top 25% of dividend payers in United States of America (3.62%).
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not
wildly increasing/decreasing each year. This graph shows you the historical rate
to count toward your assessment of the stock.We also check to see if the dividend has increased in the past 10 years.
| Data Point | Source | Value |
|---|---|---|
| Past Annualized Dividend Yield | S&P Global Market Data | See Below |
| Past Dividends per Share | Company Filings/ Annualized Dividend Payments | See Below |
| Future Dividends per Share Estimates | Average of up to 17 Analyst Estimates (S&P Global) | See Below |
| United States of America Machinery Industry Average Dividend Yield | Market Cap Weighted Average of 77 Stocks | 1.9% |
| United States of America Market Average Dividend Yield | Market Cap Weighted Average of 2008 Stocks | 2.4% |
| United States of America Minimum Threshold Dividend Yield | 10th Percentile | 0.8% |
| United States of America Bottom 25% Dividend Yield | 25th Percentile | 1.4% |
| United States of America Top 25% Dividend Yield | 75th Percentile | 3.6% |
Industry and Market average data is calculated daily.
Note all dividend per share amounts are annualized and not quarterly or other period.
| Date (Data in $) | Dividend per Share (annual) | Avg. No. Analysts |
|---|---|---|
| 2023-12-31 | 1.66 | 1.00 |
| 2022-12-31 | 1.23 | 2.00 |
| 2021-12-31 | 1.22 | 5.00 |
| 2020-12-31 | 1.07 | 10.00 |
| 2019-12-31 | 0.96 | 10.00 |
| Date (Data in $) | Dividend per share (annual) | Avg. Yield (%) |
|---|---|---|
| 2019-02-22 | 0.960 | 1.225 |
| 2019-01-31 | 0.960 | 1.331 |
| 2018-10-11 | 0.840 | 1.235 |
| 2018-08-16 | 0.840 | 1.077 |
| 2018-05-10 | 0.840 | 1.186 |
| 2018-02-01 | 0.840 | 1.118 |
| 2017-10-12 | 0.720 | 1.060 |
| 2017-08-17 | 0.720 | 1.150 |
| 2017-05-11 | 0.720 | 1.307 |
| 2017-05-02 | 0.720 | 1.405 |
| 2017-02-23 | 0.720 | 1.455 |
| 2017-02-02 | 0.720 | 1.504 |
| 2016-10-13 | 0.620 | 1.235 |
| 2016-08-17 | 0.620 | 1.218 |
| 2016-05-13 | 0.620 | 1.348 |
| 2016-05-03 | 0.620 | 1.468 |
| 2016-02-26 | 0.620 | 1.539 |
| 2016-02-04 | 0.620 | 1.671 |
| 2015-10-29 | 0.563 | 1.564 |
| 2015-05-13 | 0.563 | 1.627 |
| 2015-04-30 | 0.563 | 1.531 |
| 2015-02-26 | 0.563 | 1.588 |
| 2015-02-05 | 0.563 | 1.581 |
| 2014-10-15 | 0.512 | 1.408 |
| 2014-08-25 | 0.512 | 1.413 |
| 2014-05-07 | 0.512 | 1.364 |
| 2014-04-29 | 0.512 | 1.385 |
| 2014-02-27 | 0.512 | 1.396 |
| 2014-02-04 | 0.512 | 1.355 |
| 2013-10-10 | 0.466 | 1.407 |
| 2013-08-21 | 0.466 | 1.752 |
| 2013-05-08 | 0.466 | 1.715 |
| 2013-02-07 | 0.466 | 1.671 |
| 2012-10-12 | 0.405 | 1.549 |
| 2012-08-20 | 0.405 | 1.623 |
| 2012-05-10 | 0.405 | 1.641 |
| 2012-02-24 | 0.405 | 1.484 |
| 2011-11-02 | 0.405 | 1.599 |
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Whilst dividend payments have been stable, Xylem has been paying a dividend for less than 10 years.
- Dividend payments have increased, but Xylem only paid a dividend in the past 7 years.
Income/ dividend checks
We assess Xylem's dividend by checking for:- Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
- Is current dividend yield above the bottom 25% of dividend payers? (1 check)
- Is current dividend yield above the top 25% of dividend payers? (1 check)
- Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
- If they have paid a dividend for 10 years has it increased in this time? (1 check)
- How sustainable is the dividend, can Xylem afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks) Xylem has a total score of 2/6, see the detailed checks below.
Full details on the Dividends part of the Simply Wall St company analysis model.
Management
CEO
| COMPENSATION | $7,717,863 |
| AGE | 53 |
| TENURE AS CEO | 5.1 years |
CEO Bio
Mr. Patrick K. Decker has been the Chief Executive Officer and President of Xylem Inc. since March 17, 2014. Mr. Decker served as the Chief Executive Officer and President of Harsco Corporation from September 10, 2012 to March 2014. He served as the President of Tyco Flow Control Inc. from June 2007 to August 2012. He served as the Head of Tyco Flow Control of Tyco Fire & Security, LLC. He joined Tyco in May 2003 as the Chief Financial Officer of Tyco's Plastics & Adhesives Business and also served as its Chief Financial Officer of the Engineered Products and Services business since January 2005. He served as the President of Tyco Flow Control International Ltd., until August 8, 2012. Prior to Tyco, Mr. Decker served 13 years at Bristol-Myers Squibb in a series of key finance roles both in the U.S. and internationally, including Vice President of Finance and Business Development for the Mead Johnson Nutritionals business. He began his career as an Auditor for Price Waterhouse Coopers. He has been a Director of Xylem Inc. since March 17, 2014. He served as Director of Harsco Corporation from October 29, 2012 to March 2014. He is a Certified Public Accountant. Mr. Decker holds a BS in Accounting and Finance from Indiana University.
CEO Compensation
- Patrick's compensation has been consistent with company performance over the past year.
- Patrick's remuneration is lower than average for companies of similar size in United States of America.
Management Team Tenure
Average tenure and age of the Xylem management team in years:
- The tenure for the Xylem management team is about average.
Management Team
Patrick Decker
President
$8M
53
5.1 yrs
E. Rajkowski
Senior VP & CFO
$3M
59
3.1 yrs
Claudia Toussaint
Senior VP
$2M
54
4.5 yrs
Colin Sabol
Senior VP and President of Measurement & Control Solutions
$2M
50
8.3 yrs
Ken Napolitano
Senior VP and President of Applied Water Systems & Americas Commercial Team
$2M
56
8.3 yrs
Geri-Michelle McShane
VP, Controller & Chief Accounting Officer
44
0.1 yrs
Jay Iyengar
Chief Innovation & Technology Officer and Senior VP
3.8 yrs
Jason Chapman
Interim Chief Information Officer & VP of Global Business Services
1.6 yrs
Matt Latino
Director of Investor Relations
1.5 yrs
Kelly McAndrew
Vice President of Global Public Affairs
4.5 yrs
Board of Directors Tenure
Average tenure and age of the Xylem board of directors in years:
- The tenure for the Xylem board of directors is about average.
Board of Directors
Markos Tambakeras
Chairman of the Board
$333K
67
7.5 yrs
Patrick Decker
President
$8M
53
5.1 yrs
Steve Loranger
Independent Director
$226K
66
7.5 yrs
Curt Crawford
Independent Director
$226K
70
7.5 yrs
Victoria Harker
Independent Director
$230K
53
7.5 yrs
Rob Friel
Independent Director
$226K
62
6.3 yrs
Jerome Peribere
Independent Director
$215K
63
5.9 yrs
Surya Mohapatra
Independent Director
$215K
68
7.5 yrs
Sten Jakobsson
Independent Director
$215K
69
7.5 yrs
Jeanne Beliveau-Dunn
Director
$155K
58
1.7 yrs
Who owns this company?
Recent Insider Transactions
| Announced | Type | Name | Entity | Role | Start | End | Shares | Max Price ($) | Value ($) | |
|---|---|---|---|---|---|---|---|---|---|---|
| 18. Mar 19 | Sell | Steven Loranger | Individual | 15. Mar 19 | 15. Mar 19 | -10,000 | $76.99 | $-769,917 | ||
| 18. Mar 19 | Sell | Curtis Crawford | Individual | 14. Mar 19 | 14. Mar 19 | -7,500 | $76.60 | $-574,501 | ||
| 26. Feb 19 | Sell | Tomas Brannemo | Individual | 26. Feb 19 | 26. Feb 19 | -2,621 | $75.05 | $-196,702 | ||
| 22. Feb 19 | Sell | Tomas Brannemo | Individual | 21. Feb 19 | 21. Feb 19 | -559 | $74.44 | $-41,611 | ||
| 07. Aug 18 | Sell | Curtis Crawford | Individual | 03. Aug 18 | 07. Aug 18 | -7,500 | $76.48 | $-571,973 | ||
| 07. Aug 18 | Sell | Kairus Tarapore | Individual | 03. Aug 18 | 03. Aug 18 | -2,300 | $75.17 | $-172,891 | ||
| 15. May 18 | Sell | Curtis Crawford | Individual | 14. May 18 | 14. May 18 | -7,500 | $73.39 | $-550,395 | ||
Management checks
We assess Xylem's management by checking for:- Is the CEO's compensation unreasonable compared to market cap? (1 check)
- Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
- Is the average tenure of the management team less than 2 years? (1 check)
- Is the average tenure of the board of directors team less than 3 years? (1 check) Xylem has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.
Note: We use the top 6 management executives and board members in our calculations.
Note 2: Insider trading include any internal stakeholders and these transactions .
Full details on the Management part of the Simply Wall St company analysis model.
News
Simply Wall St News
Is Xylem Inc.'s (NYSE:XYL) CEO Paid Enough Relative To Peers?
First, this article will compare CEO compensation with compensation at other large companies. … How Does Patrick Decker's Compensation Compare With Similar Sized Companies. … has a market cap of US$15b, and is paying total annual CEO compensation of US$7.7m.
Simply Wall St - – Full articleWhat Is Xylem Inc.'s (NYSE:XYL) Share Price Doing?
led the NYSE gainers with a relatively large price hike in the past couple of weeks. … With many analysts covering the large-cap stock, we may expect any price-sensitive announcements have already been factored into the stock’s share price
Simply Wall St - – Full articleHere's What Xylem Inc.'s (NYSE:XYL) P/E Is Telling Us
The goal of this article is to teach you how to use price to earnings ratios (P/E ratios). … We'll look at Xylem Inc.'s (NYSE:XYL) P/E ratio and reflect on what it tells us about the company's share price. … Price to Earnings Ratio = Price per Share ÷ Earnings per Share (EPS)
Simply Wall St - – Full articleAre Xylem Inc.’s (NYSE:XYL) Returns On Investment Worth Your While?
In particular, we'll consider its Return On Capital Employed (ROCE), as that can give us insight into how profitably the company is able to employ capital in its business. … Return On Capital Employed (ROCE): What is it? … ROCE is a measure of a company's yearly pre-tax profit (its return), relative to the capital employed in the business.
Simply Wall St - – Full articleXylem Inc. (NYSE:XYL): Are Analysts Bullish?
Xylem Inc.'s (NYSE:XYL) announced its latest earnings update in December 2018, whicha … indicated
Simply Wall St - – Full articleXylem Shareholders Have Enjoyed A 97% Share Price Gain
(NYSE:XYL) shareholders have seen the share price rise 97% over three years, well in excess of the market return (53%). … In his essay The Superinvestors of Graham-and-Doddsville Warren Buffett described how share prices do not always rationally reflect the value of a business. … Xylem was able to grow its EPS at 18% per year over three years, sending the share price higher.
Simply Wall St - – Full articleAre Xylem Inc.'s (NYSE:XYL) Interest Costs Too High?
Help shape the future of investing tools and you could win a $250 gift card! … I will provide an overview of Xylem’s financial liquidity and leverage to give you an idea of Xylem’s position to take advantage of potential acquisitions or comfortably endure future downturns. … Note that this commentary is very high-level and solely focused on financial health, so I suggest you dig deeper yourself
Simply Wall St - – Full articleIs Xylem Inc. (NYSE:XYL) Undervalued After Accounting For Its Future Growth?
Help shape the future of investing tools and you could win a $250 gift card! … Below I will be talking through a basic metric which will help answer this question. … Analysts are predicting good growth prospects for Xylem over the next couple of years
Simply Wall St - – Full articleA Note On Xylem Inc.'s (NYSE:XYL) ROE and Debt To Equity
With that in mind, this article will work through how we can use Return On Equity (ROE) to better understand a business. … That means that for every $1 worth of shareholders' equity, it generated $0.15 in profit. … Return on Equity = Net Profit ÷ Shareholders' Equity
Simply Wall St - – Full articleHow Many Insiders Sold Xylem Inc. (NYSE:XYL) Shares?
So shareholders might well want to know whether insiders have been buying or selling shares in Xylem Inc. … Xylem Insider Transactions Over The Last Year. … We usually pause to reflect on the potential that a stock has a high valuation, if insiders have been selling at around the current price.
Simply Wall St - – Full articleCompany Info
Description
Xylem Inc. engages in the design, manufacture, and servicing of engineered products and solutions for the water and wastewater applications. It operates in three segments: Water Infrastructure, Applied Water, and Measurement & Control Solutions. The Water Infrastructure segment offers various products, including water and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment under the Flygt, Godwin, Wedeco, Sanitaire, and Leopold names for the transportation and treatment of water. The Applied Water segment provides pumps, valves, heat exchangers, controls, and dispensing equipment systems under the Goulds Water Technology, Bell & Gossett, A-C Fire Pump, Standard Xchange, Lowara, Jabsco, and Flojet brand names for residential and commercial building services, and industrial water applications. The Measurement & Control Solutions segment provides smart metering, networked communications, and measurement and control technologies, as well as critical infrastructure technologies that allow customers to use their distribution networks for the delivery, monitoring, and control of critical resources, such as water, electricity, and natural gas. It also offers software and services, including cloud-based analytics, remote monitoring, data management, leak detection, and pressure monitoring solutions and testing equipment, as well as sells smart lighting solutions. This segment sells its products under the EmNet, Pure, Sensus, Smith Blair, Valor Water, Visenti, WTW, and YSI brand names. The company markets and sells its products through a network of direct sales force, resellers, distributors, and value-added solution providers in the United States, Europe, the Asia Pacific, and internationally. Xylem Inc. is headquartered in Rye Brook, New York.
Details
| Name: | Xylem Inc. |
| XYL | |
| Exchange: | NYSE |
| Founded: | |
| $15,015,995,598 | |
| 179,853,822 | |
| Website: | http://www.xylem.com |
| Address: |
Xylem Inc. 1 International Drive, Rye Brook, New York, 10573, United States |
Listings
| Exchange Symbol | Ticker Symbol | Security | Exchange | Country | Currency | Listed on | |
|---|---|---|---|---|---|---|---|
| NYSE | XYL | Common Stock | New York Stock Exchange | US | USD | 13. Oct 2011 | |
| DB | XY6 | Common Stock | Deutsche Boerse AG | DE | EUR | 13. Oct 2011 | |
| LSE | 0M29 | Common Stock | London Stock Exchange | GB | USD | 13. Oct 2011 | |
| BMV | XYL * | Common Stock | Bolsa Mexicana de Valores | MX | MXN | 13. Oct 2011 |
Number of employees
Current staff
Industry
| Industrial Machinery | |
| Capital Goods |
Company Analysis and Financial Data Status
| Area | Date (UTC time) |
|---|---|
| Company Analysis updated: | 2019/04/23 00:36 |
| End of day share price update: | 2019/04/22 00:00 |
| Last estimates confirmation: | 2019/04/22 |
| Last earnings filing: | 2019/02/22 |
| Last earnings reported: | 2018/12/31 |
| Last annual earnings reported: | 2018/12/31 |
All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
